PFE  Pfizer Inc.




Consumer Durables


Major Pharmaceuticals

Market Cap.


Vuru Grade


Current Price

+0.18 (+0.52%)

Growth Price

Overvalued by 25.74%

Stability Price

Overvalued by 65.37%

Company Metrics

  • P/E 28.37
  • P/S 4.1
  • P/B 3.31
  • EPS 1.22
  • Cash ROIC 13.13%
  • Cash Ratio 0.79
  • Dividend 1.2 / 3.49%
  • Avg. Vol. 44.83M
  • Shares 6.06B
  • Market Cap. 209.90B

Company Description

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segment's provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diab... more

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


Billionaires Are Bailing on Pfizer, Inc -- Should You?
Motley Fool - May 24, 2016
While following blindly in the footsteps of billionaires is risky, it's always interesting to see what stocks legendary investing gurus are selling, especially when it involves a widely held stock like Pfizer, Inc. (NYSE:PFE). Last quarter, seven ...
Pfizer Inc. (NYSE:PFE)'s Syphilis Drug Shortage Threatens Affected Individuals
Market Exclusive - May 27, 2016
An interruption at a Pfizer Inc. (NYSE:PFE) plant is creating problems since the company is the only manufacturer of an approved antibiotic used in treating syphilis in pregnant women.
Top Picks from Hap Sneddon: MDA Corp, Pfizer Inc, BCE Inc - May 27, 2016
The major themes over the next few months impacting the markets will be China data and yuan devaluation, forward corporate earnings guidance and the June and July Fed meetings.
Trade Union Disagrees With Pfizer Inc (NYSE:PFE) Plan To End Traditional Pensions
Market Exclusive - May 25, 2016
Pfizer Inc. (NYSE:PFE) is rethinking its pension plan in Ireland which it describes as “not sustainable,” and since it is only increasing costs the company now wants to halt it.
Were Analysts Bullish Pfizer Inc. (NYSE:PFE) This Week?
Franklin Independent - May 28, 2016
Out of 21 analysts covering Pfizer (NYSE:PFE), 14 rate it a “Buy”, 0 “Sell”, while 9 “Hold”. This means 61% are positive.
Today's Stock in Focus: Pfizer Inc. (NYSE:PFE) - CWRU Observer
Pfizer Inc. (NYSE:PFE) Near-Term M&A Strategy: Build The Oncology Portfolio - LearnBonds
Pfizer Inc. (NYSE:PFE) Has 58 Percent Potential to Increase
The Point Review - May 25, 2016
Pfizer Inc. (NYSE:PFE) shares traded +1.28% during the most recent session. Wall Street analysts covering the stock are projecting that the stock will reach $38.62 within the next 52-weeks.
9 Figures That Sum Up Pfizer, Inc.'s First Quarter - May 3, 2016
After reporting rosy first-quarter financials and increasing its outlook for the year, Pfizer shares are trading higher. Investors wondering if Pfizer's shares should be bought or sold on this news might want to consider these nine numbers, each of ...
Pfizer Inc. (PFE) Tops Earnings Estimates With 20% Jump In Q1 Revenue - International Business Times
Is Pfizer Inc. Finally Safe To Buy Again? (PFE) -
Pfizer Inc. (PFE) Eyes Next M&A Target After Allergan Mega-Deal Fails
Business Finance News - May 17, 2016
Pfizer Inc. (NYSE:PFE) is working on multiple aspects of merger and acquisitions (M&A) after the termination of the mega deal between the former and Allergan.
Pfizer Inc. (PFE) To Acquire Anacor Pharmaceuticals Inc. (ANAC) For $5.2B - International Business Times
Healthcare Stocks Active Momentum: Pfizer Inc (NYSE:PFE) | Great Basin ... - Money News (press release)
Pfizer Inc. (NYSE:PFE) Given Average Rating of “BUY” by Brokerages
The Point Review - May 24, 2016
Pfizer Inc. (NYSE:PFE) has grabbed the attention from analysts, when it saw a value decrease of 0.15 percent in the last trading session.
Pfizer Updates CHAMPIX To Add New Safety And Efficacy Data In European Union - Benzinga
Market Movers: Pfizer Inc. (NYSE:PFE), Charles Schwab Corp (NYSE:SCHW) - NYSE Journal (press release)
Wednesday's Vital Data:, Inc. (AMZN), Pfizer Inc. (PFE) and Walt ... - May 11, 2016
Options volume remained elevated on Tuesday, with the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) still taking the lead, though Pfizer Inc. (NYSE:PFE) was close on its heels. Overall, the CBOE single-session equity put/call volume ratio remained volatile, ...